Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460538
Status:
COMPLETED
Last Update Posted:
2010-04-05
First Post:
2007-04-13
Brief Title:
Efficacy and Safety of Lectranal in Treatment of Seasonal Allergic Rhinitis Symptoms
Sponsor:
Milsing doo
Organization:
Milsing doo
Study Overview
Official Title:
Efficacy and Safety of Lectranal in Treatment of Seasonal Allergic Rhinitis Symptoms
Status:
COMPLETED
Status Verified Date:
2010-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine weather Lectranal is effective in treatment of seasonal allergic rhinitis symptoms
Detailed Description:
Patients allergic to the specific pollen are divided into two groups randomly One group is being administered Lectranal and the other group is being administered placebo during the period of 6 weeks in season of the pollen Methods used for evaluation are SARS questionnaireseasonal allergic rhinitis symptoms Mini RQLQ mini rhinoconjunctivitis quality of life questionnaire skin Prick test specific IgE and IgG eosinophilia in nasal secretion Methods used for follow up safety include side effects report physical examination and vital signs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None